{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:15:42Z","timestamp":1718763342057},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2003,5,1]]},"DOI":"10.1038\/sj.gt.3302041","type":"journal-article","created":{"date-parts":[[2003,5,6]],"date-time":"2003-05-06T11:49:51Z","timestamp":1052221791000},"page":"835-843","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Celiac Disease: a model autoimmune disease with gene therapy applications"],"prefix":"10.1038","volume":"10","author":[{"given":"M","family":"Londei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Quaratino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Maiuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,6]]},"reference":[{"key":"BF3302041_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/35038533","volume":"1","author":"N Somia","year":"2000","unstructured":"Somia N, Verma IM . Gene therapy: trials and tribulations. Nat Rev Genet 2000; 1: 91\u201399.","journal-title":"Nat Rev Genet"},{"key":"BF3302041_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/38410","volume":"389","author":"IM Verma","year":"1997","unstructured":"Verma IM, Somia N . Gene therapy \u2013 promises, problems and prospects. Nature 1997; 389: 239\u2013242.","journal-title":"Nature"},{"key":"BF3302041_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/sj.gt.3301791","volume":"9","author":"U Griesenbach","year":"2002","unstructured":"Griesenbach U, Ferrari S, Geddes DM, Alton EW . Gene therapy progress and prospects: cystic fibrosis. Gene Ther 2002; 9: 1344\u20131350.","journal-title":"Gene Ther"},{"key":"BF3302041_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nri859","volume":"2","author":"A Fischer","year":"2002","unstructured":"Fischer A, Hacein-Bey S, Cavazzana-Calvo M . Gene therapy of severe combined immunodeficiencies. Nat Rev Immunol 2002; 2: 615\u2013621.","journal-title":"Nat Rev Immunol"},{"key":"BF3302041_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/ni1001-957","volume":"2","author":"HW Kessels","year":"2001","unstructured":"Kessels HW, Wolkers MC, van dB, van der Valk MA, Schumacher TN . Immunotherapy through TCR gene transfer. Nat Immunol 2001; 2: 957\u2013961.","journal-title":"Nat Immunol"},{"key":"BF3302041_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1365-3083.1994.tb03383.x","volume":"39","author":"ED Thomas","year":"1994","unstructured":"Thomas ED . The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1990. Bone marrow transplantation \u2013 past, present and future. Scand J Immunol 1994; 39: 339\u2013345.","journal-title":"Scand J Immunol"},{"key":"BF3302041_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11926-000-0026-6","volume":"2","author":"F Viganego","year":"2000","unstructured":"Viganego F, Nash R, Furst DE . Bone marrow transplantation in the treatment of systemic sclerosis. Curr Rheumatol Rep 2000; 2: 492\u2013500.","journal-title":"Curr Rheumatol Rep"},{"key":"BF3302041_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s004150070112","volume":"247","author":"P Mandalfino","year":"2000","unstructured":"Mandalfino P et al. Bone marrow transplantation in multiple sclerosis. J Neurol 2000; 247: 691\u2013695.","journal-title":"J Neurol"},{"key":"BF3302041_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00001622-199903000-00002","volume":"11","author":"RA Brodsky","year":"1999","unstructured":"Brodsky RA, Smith BD . Bone marrow transplantation for autoimmune diseases. Curr Opin Oncol 1999; 11: 83\u201386.","journal-title":"Curr Opin Oncol"},{"key":"BF3302041_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/sj.gt.3300436","volume":"4","author":"Y Chernajovsky","year":"1997","unstructured":"Chernajovsky Y, Adams G, Triantaphyllopoulos K, Ledda MF, Podhajcer OL . Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model. Gene Ther 1997; 4: 553\u2013559.","journal-title":"Gene Ther"},{"key":"BF3302041_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1172\/JCI12037","volume":"107","author":"A Nakajima","year":"2001","unstructured":"Nakajima A et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001; 107: 1293\u20131301.","journal-title":"J Clin Invest"},{"key":"BF3302041_CR12","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.185.9.1711","volume":"185","author":"MK Shaw","year":"1997","unstructured":"Shaw MK et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997; 185: 1711\u20131714.","journal-title":"J Exp Med"},{"key":"BF3302041_CR13","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI11490","volume":"107","author":"Y Morita","year":"2001","unstructured":"Morita Y et al. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest 2001; 107: 1275\u20131284.","journal-title":"J Clin Invest"},{"key":"BF3302041_CR14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.162.3.1423","volume":"162","author":"HG Zhang","year":"1999","unstructured":"Zhang HG et al. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J Immunol 1999; 162: 1423\u20131430.","journal-title":"J Immunol"},{"key":"BF3302041_CR15","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2","volume":"42","author":"T Tomita","year":"1999","unstructured":"Tomita T et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 1999; 42: 2532\u20132542.","journal-title":"Arthritis Rheum"},{"key":"BF3302041_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/1529-0131(200005)43:5<1094::AID-ANR20>3.0.CO;2-V","volume":"43","author":"HG Zhang","year":"2000","unstructured":"Zhang HG et al. Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts. Arthritis Rheum 2000; 43: 1094\u20131105.","journal-title":"Arthritis Rheum"},{"key":"BF3302041_CR17","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(96)70237-4","volume":"349","author":"M Maki","year":"1997","unstructured":"Maki M, Collin P . Coeliac disease. Lancet 1997; 349: 1755\u20131759.","journal-title":"Lancet"},{"key":"BF3302041_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/gast.2001.22123","volume":"120","author":"A Fasano","year":"2001","unstructured":"Fasano A, Catassi C . Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636\u2013651.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR19","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1053\/gast.2002.36850","volume":"123","author":"CG Loftus","year":"2002","unstructured":"Loftus CG, Loftus Jr EV . Cancer risk in celiac disease. Gastroenterology 2002; 123: 1726\u20131729.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev.immunol.18.1.53","volume":"18","author":"LM Sollid","year":"2000","unstructured":"Sollid LM . Molecular basis of celiac disease. Annu Rev Immunol 2000; 18: 53\u201381.","journal-title":"Annu Rev Immunol"},{"key":"BF3302041_CR21","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1053\/gast.1996.v110.pm8613040","volume":"110","author":"L Maiuri","year":"1996","unstructured":"Maiuri L et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996; 110: 1368\u20131378.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0016-5085(98)70135-0","volume":"115","author":"L Maiuri","year":"1998","unstructured":"Maiuri L et al. Blockage of T-cell costimulation inhibits T-cell action in celiac disease. Gastroenterology 1998; 115: 564\u2013572.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/gut.52.2.199","volume":"52","author":"IR Korponay-Szabo","year":"2003","unstructured":"Korponay-Szabo IR et al. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues. Gut 2003; 52: 199\u2013204.","journal-title":"Gut"},{"key":"BF3302041_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/0140-6736(91)91445-Z","volume":"338","author":"M Maki","year":"1991","unstructured":"Maki M, Hallstrom O, Marttinen A . Reaction of human non-collagenous polypeptides with coeliac disease autoantibodies. Lancet 1991; 338: 724\u2013725.","journal-title":"Lancet"},{"key":"BF3302041_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/gut.36.2.239","volume":"36","author":"M Maki","year":"1995","unstructured":"Maki M, Huupponen T, Holm K, Hallstrom O . Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus. Gut 1995; 36: 239\u2013242.","journal-title":"Gut"},{"key":"BF3302041_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/00365519850186166","volume":"58","author":"W Amara","year":"1998","unstructured":"Amara W, Husebekk A . Improved method for serological testing in celiac disease \u2013 IgA anti-endomysium antibody test: a comparison between monkey oesophagus and human umbilical cord as substrate in indirect immunofluorescence test. Scand J Clin Lab Invest 1998; 58: 547\u2013554.","journal-title":"Scand J Clin Lab Invest"},{"key":"BF3302041_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich W et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797\u2013801.","journal-title":"Nat Med"},{"key":"BF3302041_CR28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0016-5085(98)70007-1","volume":"115","author":"W Dieterich","year":"1998","unstructured":"Dieterich W et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317\u20131321.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR29","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S0016-5085(98)70008-3","volume":"115","author":"S Sulkanen","year":"1998","unstructured":"Sulkanen S et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322\u20131328.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nm0698-713","volume":"4","author":"O Molberg","year":"1998","unstructured":"Molberg O et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713\u2013717.","journal-title":"Nat Med"},{"key":"BF3302041_CR31","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.4049\/jimmunol.161.4.1585","volume":"161","author":"WY van de","year":"1998","unstructured":"van de WY et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585\u20131588.","journal-title":"J Immunol"},{"key":"BF3302041_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1084\/jem.183.2.349","volume":"183","author":"S Quaratino","year":"1996","unstructured":"Quaratino S, Feldmann M, Dayan CM, Acuto O, Londei M . Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope. J Exp Med 1996; 183: 349\u2013358.","journal-title":"J Exp Med"},{"key":"BF3302041_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.180.2.745","volume":"180","author":"E Michaelsson","year":"1994","unstructured":"Michaelsson E et al. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994; 180: 745\u2013749.","journal-title":"J Exp Med"},{"key":"BF3302041_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ni754","volume":"3","author":"B Manoury","year":"2002","unstructured":"Manoury B et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat Immunol 2002; 3: 169\u2013174.","journal-title":"Nat Immunol"},{"key":"BF3302041_CR35","doi-asserted-by":"crossref","unstructured":"Anderton SM, Viner NJ, Matharu P, Lowrey PA, Wraith DC . Influence of a dominant cryptic epitope on autoimmune T cell tolerance. Nat Immunol (2002).","DOI":"10.1038\/ni756"},{"key":"BF3302041_CR36","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1126\/science.1074129","volume":"297","author":"L Shan","year":"2002","unstructured":"Shan L et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275\u20132279.","journal-title":"Science"},{"key":"BF3302041_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.191.4.603","volume":"191","author":"H Arentz-Hansen","year":"2000","unstructured":"Arentz-Hansen H et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000; 191: 603\u2013612.","journal-title":"J Exp Med"},{"key":"BF3302041_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/gut.34.2.208","volume":"34","author":"T Kutlu","year":"1993","unstructured":"Kutlu T et al. Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 1993; 34: 208\u2013214.","journal-title":"Gut"},{"key":"BF3302041_CR39","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0016-5085(00)70173-9","volume":"118","author":"B Jabri","year":"2000","unstructured":"Jabri B et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000; 118: 867\u2013879.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR40","first-page":"150","volume":"96","author":"L Maiuri","year":"2001","unstructured":"Maiuri L et al. IL-15 drives the specific migration of CD94+ and TCR-gamma delta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. Am J Gastroenterol 2001; 96: 150\u2013156.","journal-title":"Am J Gastroenterol"},{"key":"BF3302041_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/gut.48.3.418","volume":"48","author":"L Maiuri","year":"2001","unstructured":"Maiuri L et al. FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut 2001; 48: 418\u2013424.","journal-title":"Gut"},{"key":"BF3302041_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1365-2249.2002.01795.x","volume":"128","author":"R Ciccocioppo","year":"2002","unstructured":"Ciccocioppo R et al. Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease. Clin Exp Immunol 2002; 128: 88\u201393.","journal-title":"Clin Exp Immunol"},{"key":"BF3302041_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer S et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727\u2013729.","journal-title":"Science"},{"key":"BF3302041_CR44","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/gast.2000.18149","volume":"119","author":"L Maiuri","year":"2000","unstructured":"Maiuri L et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000; 119: 996\u20131006.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/gast.2002.35355","volume":"123","author":"G Forsberg","year":"2002","unstructured":"Forsberg G et al. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 2002; 123: 667\u2013678.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/gut.36.6.874","volume":"36","author":"RT Przemioslo","year":"1995","unstructured":"Przemioslo RT et al. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 1995; 36: 874\u2013879.","journal-title":"Gut"},{"key":"BF3302041_CR47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0016-5085(98)70134-9","volume":"115","author":"EM Nilsen","year":"1998","unstructured":"Nilsen EM et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115: 551\u2013563.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1182\/blood.V97.1.14","volume":"97","author":"TA Fehniger","year":"2001","unstructured":"Fehniger TA, Caligiuri MA . Interleukin 15: biology and relevance to human disease. Blood 2001; 97: 14\u201332.","journal-title":"Blood"},{"key":"BF3302041_CR49","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.4049\/jimmunol.166.10.6399","volume":"166","author":"P Bu","year":"2001","unstructured":"Bu P et al. Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J Immunol 2001; 166: 6399\u20136403.","journal-title":"J Immunol"},{"key":"BF3302041_CR50","first-page":"105","volume":"14","author":"TA Waldmann","year":"2001","unstructured":"Waldmann TA, Dubois S, Tagaya Y . Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001; 14: 105\u2013110.","journal-title":"Immunity"},{"key":"BF3302041_CR51","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.160.11.5654","volume":"160","author":"H Ruchatz","year":"1998","unstructured":"Ruchatz H et al. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 1998; 160: 5654\u20135660.","journal-title":"J Immunol"},{"key":"BF3302041_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","volume":"356","author":"C Cellier","year":"2000","unstructured":"Cellier C et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000; 356: 203\u2013208.","journal-title":"Lancet"},{"key":"BF3302041_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0140-6736(01)05554-4","volume":"358","author":"G Corrao","year":"2001","unstructured":"Corrao G et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356\u2013361.","journal-title":"Lancet"},{"key":"BF3302041_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1084\/jem.190.3.385","volume":"190","author":"GA Rabinovich","year":"1999","unstructured":"Rabinovich GA et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999; 190: 385\u2013398.","journal-title":"J Exp Med"},{"key":"BF3302041_CR55","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/sj.gt.3301149","volume":"7","author":"A Annenkov","year":"2000","unstructured":"Annenkov A, Chernajovsky Y . Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta. Gene Ther 2000; 7: 714\u2013722.","journal-title":"Gene Ther"},{"key":"BF3302041_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","volume":"74","author":"C Berlin","year":"1993","unstructured":"Berlin C et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993; 74: 185.","journal-title":"Cell"},{"key":"BF3302041_CR57","first-page":"97","volume":"151","author":"M Briskin","year":"1997","unstructured":"Briskin M et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997; 151: 97\u2013110.","journal-title":"Am J Pathol"},{"key":"BF3302041_CR58","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gut.46.3.344","volume":"46","author":"G Barbara","year":"2000","unstructured":"Barbara G et al. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 2000; 46: 344\u2013349.","journal-title":"Gut"},{"key":"BF3302041_CR59","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/gut.44.6.800","volume":"44","author":"S Wirtz","year":"1999","unstructured":"Wirtz S, Galle PR, Neurath MF . Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure. Gut 1999; 44: 800\u2013807.","journal-title":"Gut"},{"key":"BF3302041_CR60","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","volume":"289","author":"L Steidler","year":"2000","unstructured":"Steidler L et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1352\u20131355.","journal-title":"Science"},{"key":"BF3302041_CR61","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/gast.2002.37067","volume":"123","author":"C Van Montfrans","year":"2002","unstructured":"Van Montfrans C et al. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology 2002; 123: 1865\u20131876.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR62","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1089\/10430349950017202","volume":"10","author":"KE Pollok","year":"1999","unstructured":"Pollok KE et al. Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus. Hum Gene Ther 1999; 10: 2221\u20132236.","journal-title":"Hum Gene Ther"},{"key":"BF3302041_CR63","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1053\/gast.2002.37066","volume":"123","author":"C Van Montfrans","year":"2002","unstructured":"Van Montfrans C et al. Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer. Gastroenterology 2002; 123: 1877\u20131888.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR64","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood.V94.10.3349.422k05_3349_3357","volume":"94","author":"S Halene","year":"1999","unstructured":"Halene S et al. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood 1999; 94: 3349\u20133357.","journal-title":"Blood"},{"key":"BF3302041_CR65","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.270.5235.475","volume":"270","author":"RM Blaese","year":"1995","unstructured":"Blaese RM et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 1995; 270: 475\u2013480.","journal-title":"Science"},{"key":"BF3302041_CR66","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","volume":"276","author":"C Bonini","year":"1997","unstructured":"Bonini C et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719\u20131724.","journal-title":"Science"},{"key":"BF3302041_CR67","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0016-5085(99)70178-2","volume":"116","author":"T Halttunen","year":"1999","unstructured":"Halttunen T, Maki M . Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999; 116: 566\u2013572.","journal-title":"Gastroenterology"},{"key":"BF3302041_CR68","doi-asserted-by":"publisher","first-page":"26978","DOI":"10.1074\/jbc.274.38.26978","volume":"274","author":"S Dubois","year":"1999","unstructured":"Dubois S et al. Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem 1999; 274: 26978\u201326984.","journal-title":"J Biol Chem"},{"key":"BF3302041_CR69","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4049\/jimmunol.167.1.277","volume":"167","author":"X Wei","year":"2001","unstructured":"Wei X et al. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. J Immunol 2001; 167: 277\u2013282.","journal-title":"J Immunol"},{"key":"BF3302041_CR70","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","volume":"17","author":"S Dubois","year":"2002","unstructured":"Dubois S, Mariner J, Waldmann TA, Tagaya Y . IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002; 17: 537\u2013547.","journal-title":"Immunity"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302041","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T07:38:41Z","timestamp":1682494721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,5,1]]}},"alternative-id":["BF3302041"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302041","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]},"assertion":[{"value":"6 May 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}